ID GAG_RSVP Reviewed; 701 AA. AC P03322; Q77YH0; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 21-JUL-1986, sequence version 1. DT 04-NOV-2026, entry version 167. DE RecName: Full=Gag polyprotein; DE Contains: DE RecName: Full=Matrix protein p19; DE Contains: DE RecName: Full=p2A; DE Contains: DE RecName: Full=p2B; DE Contains: DE RecName: Full=p10; DE Contains: DE RecName: Full=Capsid protein p27, alternate cleaved 1; DE Contains: DE RecName: Full=Capsid protein p27, alternate cleaved 2; DE Contains: DE RecName: Full=Spacer peptide; DE Short=SP; DE AltName: Full=p3; DE Contains: DE RecName: Full=Nucleocapsid protein p12; DE AltName: Full=NCp12 {ECO:0000250|UniProtKB:P0C776}; DE Contains: DE RecName: Full=Protease p15; DE EC=3.4.23.- {ECO:0000255|PROSITE-ProRule:PRU00275}; GN Name=gag; OS Rous sarcoma virus subgroup C (strain Prague) (RSV-Pr-C). OC Viruses; Riboviria; Pararnavirae; Artverviricota; Revtraviricetes; OC Ortervirales; Retroviridae; Orthoretrovirinae; Alpharetrovirus; OC Alpharetrovirus avirousar; Rous sarcoma virus. OX NCBI_TaxID=11888; OH NCBI_TaxID=9031; Gallus gallus (Chicken). RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC RNA]. RX PubMed=6299578; DOI=10.1016/0092-8674(83)90071-5; RA Schwartz D., Tizard R., Gilbert W.; RT "Nucleotide sequence of Rous sarcoma virus."; RL Cell 32:853-869(1983). RN [2] RP PROTEIN SEQUENCE OF 489-577. RA Misono K.S., Sharief F.S., Leis J.; RT "Primary structure of Rous sarcoma virus RNA-associated polypeptide."; RL Fed. Proc. 39:1611-1611(1980). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Reipen I.G., Sahm H., Sprenger G.A.; RL Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP PROTEOLYTIC CLEAVAGE (GAG POLYPROTEIN). RX PubMed=7666544; DOI=10.1128/jvi.69.10.6430-6438.1995; RA Pepinsky R.B., Papayannopoulos I.A., Chow E.P., Krishna N.K., Craven R.C., RA Vogt V.M.; RT "Differential proteolytic processing leads to multiple forms of the CA RT protein in avian sarcoma and leukemia viruses."; RL J. Virol. 69:6430-6438(1995). RN [5] RP PROTEOLYTIC CLEAVAGE (GAG POLYPROTEIN). RX PubMed=8636100; DOI=10.1074/jbc.271.12.6781; RA Tozser J., Bagossi P., Weber I.T., Copeland T.D., Oroszlan S.; RT "Comparative studies on the substrate specificity of avian myeloblastosis RT virus proteinase and lentiviral proteinases."; RL J. Biol. Chem. 271:6781-6788(1996). RN [6] RP PROTEOLYTIC CLEAVAGE (GAG POLYPROTEIN). RX PubMed=8627817; DOI=10.1128/jvi.70.5.3313-3318.1996; RA Pepinsky R.B., Papayannopoulos I.A., Campbell S., Vogt V.M.; RT "Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates RT trimming by host exopeptidase."; RL J. Virol. 70:3313-3318(1996). RN [7] RP RIBOSOMAL FRAMESHIFTING (GAG POLYPROTEIN). RX PubMed=9813113; DOI=10.1006/jmbi.1998.2186; RA Marczinke B., Fisher R., Vidakovic M., Bloys A.J., Brierley I.; RT "Secondary structure and mutational analysis of the ribosomal frameshift RT signal of rous sarcoma virus."; RL J. Mol. Biol. 284:205-225(1998). RN [8] RP DOMAIN (GAG POLYPROTEIN), AND MUTAGENESIS OF PRO-172 AND 180-LEU--LEU-184. RX PubMed=20392845; DOI=10.1128/jvi.00238-10; RA Dilley K.A., Gregory D., Johnson M.C., Vogt V.M.; RT "An LYPSL late domain in the gag protein contributes to the efficient RT release and replication of Rous sarcoma virus."; RL J. Virol. 84:6276-6287(2010). RN [9] RP SUBCELLULAR LOCATION (GAG POLYPROTEIN), DOMAIN (GAG POLYPROTEIN), AND RP MUTAGENESIS OF LEU-219; 524-LYS--LYS-527 AND 549-ARG--ARG-551. RX PubMed=23036987; DOI=10.1016/j.virusres.2012.09.011; RA Lochmann T.L., Bann D.V., Ryan E.P., Beyer A.R., Mao A., Cochrane A., RA Parent L.J.; RT "NC-mediated nucleolar localization of retroviral gag proteins."; RL Virus Res. 171:304-318(2013). RN [10] RP FUNCTION (SPACER PEPTIDE), AND SUBCELLULAR LOCATION (GAG POLYPROTEIN). RX PubMed=26676779; DOI=10.1128/jvi.02733-15; RA Dick R.A., Barros M., Jin D., Loesche M., Vogt V.M.; RT "Membrane Binding of the Rous Sarcoma Virus Gag Protein Is Cooperative and RT Dependent on the Spacer Peptide Assembly Domain."; RL J. Virol. 90:2473-2485(2015). RN [11] RP FUNCTION (SPACER PEPTIDE), FUNCTION (CAPSID PROTEIN P27), AND SUBUNIT RP (CAPSID PROTEIN P27). RX PubMed=28588198; DOI=10.1038/s41598-017-02060-0; RA Jaballah S.A., Bailey G.D., Desfosses A., Hyun J., Mitra A.K., RA Kingston R.L.; RT "In vitro assembly of the Rous sarcoma virus capsid protein into hexamer RT tubes at physiological temperature."; RL Sci. Rep. 7:2913-2913(2017). RN [12] RP FUNCTION (CAPSID PROTEIN P27). RX PubMed=34050170; DOI=10.1038/s41467-021-23506-0; RA Obr M., Ricana C.L., Nikulin N., Feathers J.R., Klanschnig M., Thader A., RA Johnson M.C., Vogt V.M., Schur F.K.M., Dick R.A.; RT "Structure of the mature Rous sarcoma virus lattice reveals a role for IP6 RT in the formation of the capsid hexamer."; RL Nat. Commun. 12:3226-3226(2021). RN [13] RP X-RAY CRYSTALLOGRAPHY, AND SUBUNIT (PROTEASE). RX PubMed=2536902; DOI=10.1038/337576a0; RA Miller M., Jaskolski M., Rao J.K.M., Leis J., Wlodawer A.; RT "Crystal structure of a retroviral protease proves relationship to aspartic RT protease family."; RL Nature 337:576-579(1989). RN [14] {ECO:0007744|PDB:2RSP} RP X-RAY CRYSTALLOGRAPHY, AND SUBUNIT (PROTEASE P15). RX PubMed=2166563; DOI=10.1021/bi00477a002; RA Jaskolski M., Miller M., Rao J.K., Leis J., Wlodawer A.; RT "Structure of the aspartic protease from Rous sarcoma retrovirus refined at RT 2-A resolution."; RL Biochemistry 29:5889-5898(1990). RN [15] {ECO:0007744|PDB:1BAI} RP X-RAY CRYSTALLOGRAPHY OF MUTANT SER-615; ILE-619; ILE-621; MET-650; RP ALA-677; VAL-681; ARG-682; GLY-683; SER-684 WITH INHIBITOR. RC STRAIN=S9 variant; RX PubMed=9521772; DOI=10.1021/bi972183g; RA Wu J., Adomat J.M., Ridky T.W., Louis J.M., Leis J., Harrison R.W., RA Weber I.T.; RT "Structural basis for specificity of retroviral proteases."; RL Biochemistry 37:4518-4526(1998). RN [16] RP STRUCTURE BY NMR OF 1-87. RX PubMed=9642071; DOI=10.1006/jmbi.1998.1788; RA McDonnell J.M., Fushman D., Cahill S.M., Zhou W., Wolven A., Wilson C.B., RA Nelle T.D., Resh M.D., Wills J., Cowburn D.; RT "Solution structure and dynamics of the bioactive retroviral M domain from RT Rous sarcoma virus."; RL J. Mol. Biol. 279:921-928(1998). RN [17] {ECO:0007744|PDB:1EM9, ECO:0007744|PDB:1EOQ} RP X-RAY CRYSTALLOGRAPHY, FUNCTION (CAPSID PROTEIN P27), AND SUBUNIT (CAPSID RP PROTEIN P27). RX PubMed=10873863; DOI=10.1016/s0969-2126(00)00148-9; RA Kingston R.L., Fitzon-Ostendorp T., Eisenmesser E.Z., Schatz G.W., RA Vogt V.M., Post C.B., Rossmann M.G.; RT "Structure and self-association of the Rous sarcoma virus capsid protein."; RL Structure 8:617-628(2000). RN [18] {ECO:0007744|PDB:1P7N} RP X-RAY CRYSTALLOGRAPHY, AND SUBUNIT (CAPSID PROTEIN P27). RX PubMed=14659756; DOI=10.1016/j.jmb.2003.10.034; RA Nandhagopal N., Simpson A.A., Johnson M.C., Francisco A.B., Schatz G.W., RA Rossmann M.G., Vogt V.M.; RT "Dimeric rous sarcoma virus capsid protein structure relevant to immature RT Gag assembly."; RL J. Mol. Biol. 335:275-282(2004). RN [19] {ECO:0007829|PDB:2IHX} RP STRUCTURE BY NMR OF 503-563 IN COMPLEX WITH ZINC, AND FUNCTION RP (NUCLEOCAPSID PROTEIN P12). RX PubMed=17070546; DOI=10.1016/j.jmb.2006.10.013; RA Zhou J., Bean R.L., Vogt V.M., Summers M.; RT "Solution structure of the Rous sarcoma virus nucleocapsid protein: muPsi RT RNA packaging signal complex."; RL J. Mol. Biol. 365:453-467(2007). RN [20] {ECO:0007744|PDB:3G0V, ECO:0007744|PDB:3G1G, ECO:0007744|PDB:3G1I, ECO:0007744|PDB:3G21, ECO:0007744|PDB:3G26, ECO:0007744|PDB:3G28, ECO:0007744|PDB:3G29} RP X-RAY CRYSTALLOGRAPHY, SUBUNIT (CAPSID PROTEIN P27), AND DOMAIN (CAPSID RP PROTEIN P27). RX PubMed=19446529; DOI=10.1016/j.str.2009.03.010; RA Bailey G.D., Hyun J.K., Mitra A.K., Kingston R.L.; RT "Proton-linked dimerization of a retroviral capsid protein initiates capsid RT assembly."; RL Structure 17:737-748(2009). RN [21] {ECO:0007744|PDB:2X8Q} RP STRUCTURE BY ELECTRON MICROSCOPY, SUBUNIT (CAPSID PROTEIN P27), AND DOMAIN RP (CAPSID PROTEIN P27). RX PubMed=20228062; DOI=10.1074/jbc.m110.108209; RA Hyun J.K., Radjainia M., Kingston R.L., Mitra A.K.; RT "Proton-driven assembly of the Rous sarcoma virus capsid protein results in RT the formation of icosahedral particles."; RL J. Biol. Chem. 285:15056-15064(2010). RN [22] {ECO:0007744|PDB:5A9E} RP STRUCTURE BY ELECTRON MICROSCOPY, FUNCTION (GAG POLYPROTEIN), AND SUBUNIT RP (GAG POLYPROTEIN). RX PubMed=26223638; DOI=10.1128/jvi.01502-15; RA Schur F.K., Dick R.A., Hagen W.J., Vogt V.M., Briggs J.A.; RT "The structure of immature virus-like Rous sarcoma virus gag particles RT reveals a structural role for the p10 domain in assembly."; RL J. Virol. 89:10294-10302(2015). CC -!- FUNCTION: [Gag polyprotein]: The p10 domain folds back and interacts CC with the capsid protein domain during Gag polyprotein assembly in the CC immature particle (before the maturation cleavage that splits the 2 CC domains). {ECO:0000269|PubMed:26223638}. CC -!- FUNCTION: [Capsid protein p27, alternate cleaved 1]: Self-associates to CC form the irregular polyhedron core composed of hexamers and pentamers, CC that encapsulates the genomic RNA-nucleocapsid complex. Assembles as a CC tube in vitro (PubMed:10873863, PubMed:28588198). Binds to inositol CC hexakisphosphate (IP6), which allows the assembly of the polyhedral CC capsid (PubMed:34050170). {ECO:0000269|PubMed:10873863, CC ECO:0000269|PubMed:28588198, ECO:0000269|PubMed:34050170}. CC -!- FUNCTION: [Capsid protein p27, alternate cleaved 2]: Self-associates to CC form the irregular polyhedron core composed of hexamers and pentamers, CC that encapsulates the genomic RNA-nucleocapsid complex. Assembles as a CC tube in vitro (PubMed:10873863, PubMed:28588198). Binds to inositol CC hexakisphosphate (IP6), which allows the assembly of the polyhedral CC capsid (PubMed:34050170). {ECO:0000269|PubMed:10873863, CC ECO:0000269|PubMed:28588198, ECO:0000269|PubMed:34050170}. CC -!- FUNCTION: [Nucleocapsid protein p12]: Binds strongly to viral nucleic CC acids and promotes their packaging (PubMed:17070546). Plays a role in CC the maturation-stabilization of the viral dimeric RNA via highly CC structured zinc-binding motifs (By similarity). CC {ECO:0000250|UniProtKB:P0C776, ECO:0000269|PubMed:17070546}. CC -!- FUNCTION: [Spacer peptide]: Plays a role in the oligomerization of the CC Gag polyprotein and in the stabilization of the immature particle CC (PubMed:28588198). Essential layering element during tube assembly that CC is progressively removed as capsid assembly proceeds (PubMed:28588198). CC Allows the cooperative binging of Gag to the host plasma membrane CC (PubMed:26676779). {ECO:0000269|PubMed:26676779, CC ECO:0000269|PubMed:28588198}. CC -!- FUNCTION: [Protease p15]: Aspartyl protease that mediates proteolytic CC cleavages of Gag and Gag-Pol polyproteins during or shortly after the CC release of the virion from the plasma membrane. Cleavages take place as CC an ordered, step-wise cascade to yield mature proteins. This process is CC called maturation. Displays maximal activity during the budding process CC just prior to particle release from the cell. {ECO:0000255|PROSITE- CC ProRule:PRU00275}. CC -!- SUBUNIT: [Protease p15]: Active as a homodimer (PubMed:2166563, CC PubMed:2536902). {ECO:0000269|PubMed:2166563, CC ECO:0000269|PubMed:2536902}. CC -!- SUBUNIT: [Capsid protein p27, alternate cleaved 1]: Homodimer CC (PubMed:10873863, PubMed:14659756, PubMed:19446529, PubMed:20228062). CC Homomultimer (PubMed:10873863, PubMed:14659756, PubMed:19446529, CC PubMed:20228062). Homohexamer (PubMed:28588198). CC {ECO:0000269|PubMed:10873863, ECO:0000269|PubMed:14659756, CC ECO:0000269|PubMed:19446529, ECO:0000269|PubMed:20228062, CC ECO:0000269|PubMed:28588198}. CC -!- SUBUNIT: [Capsid protein p27, alternate cleaved 2]: Homodimer CC (PubMed:10873863, PubMed:14659756, PubMed:19446529, PubMed:20228062). CC Homomultimer (PubMed:10873863, PubMed:14659756, PubMed:19446529, CC PubMed:20228062). Homohexamer (PubMed:28588198). CC {ECO:0000269|PubMed:10873863, ECO:0000269|PubMed:14659756, CC ECO:0000269|PubMed:19446529, ECO:0000269|PubMed:20228062, CC ECO:0000269|PubMed:28588198}. CC -!- SUBUNIT: [Gag polyprotein]: Homohexamer (PubMed:26223638). Interacts CC (via p2B domain) with host PACSIN2; this interaction probably allows CC PACSIN2 recruitment to viral assembly sites (By similarity). CC {ECO:0000250|UniProtKB:P0C776, ECO:0000269|PubMed:26223638}. CC -!- SUBCELLULAR LOCATION: [Matrix protein p19]: Virion {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Capsid protein p27, alternate cleaved 1]: Virion CC {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Capsid protein p27, alternate cleaved 2]: Virion CC {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Nucleocapsid protein p12]: Virion {ECO:0000305}. CC -!- SUBCELLULAR LOCATION: [Gag polyprotein]: Host nucleus, host nucleolus CC {ECO:0000269|PubMed:23036987}. Host nucleus, host nucleoplasm CC {ECO:0000269|PubMed:23036987}. Host cell membrane CC {ECO:0000269|PubMed:26676779}. Note=Shuttles between nucleoplasm and CC nucleolus. {ECO:0000269|PubMed:23036987}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Ribosomal frameshifting; Named isoforms=2; CC Comment=Translation results in the formation of the Gag polyprotein. CC Ribosomal frameshifting at the gag/pol genes boundary produces the CC Gag-Pol polyprotein. {ECO:0000269|PubMed:9813113}; CC Name=Gag polyprotein; CC IsoId=P03322-1; Sequence=Displayed; CC Name=Gag-Pol polyprotein; CC IsoId=P03354-1; Sequence=External; CC -!- DOMAIN: [Gag polyprotein]: Late-budding domains (L domains) are short CC sequence motifs essential for viral particle release. They can occur CC individually or in close proximity within structural proteins. They CC interacts with sorting cellular proteins of the multivesicular body CC (MVB) pathway. Most of these proteins are class E vacuolar protein CC sorting factors belonging to ESCRT-I, ESCRT-II or ESCRT-III complexes. CC P2B contains two L domains: a PPXY motif which probably binds to the WW CC domains of HECT (homologous to E6-AP C-terminus) E3 ubiquitin ligases CC and a LYPX(n)L domain which is known to bind the Alix adaptator CC protein. {ECO:0000269|PubMed:20392845}. CC -!- DOMAIN: [Gag polyprotein]: Contains a nuclear export signal in p10 and CC a nucleolar localization signal in nucleocapsid protein p12. CC {ECO:0000269|PubMed:23036987}. CC -!- DOMAIN: Capsid protein p27: Proton-driven dimerization of the C- CC terminus facilitates capsid assembly. {ECO:0000269|PubMed:19446529, CC ECO:0000269|PubMed:20228062}. CC -!- PTM: [Gag polyprotein]: Specific enzymatic cleavages in vivo yield CC mature proteins (PubMed:8627817, PubMed:8636100). The cleavage at the CC C-terminus of the Capsid protein p27 is slowly trimmed by the viral CC protease, sometimes being cut internally thereby generating the short CC version of the capsid protein and a capsid protein C-terminally CC extended by 3 amino acids in a ratio of 2:1 (PubMed:7666544). CC {ECO:0000269|PubMed:7666544, ECO:0000269|PubMed:8627817, CC ECO:0000269|PubMed:8636100}. CC -!- MISCELLANEOUS: [Isoform Gag polyprotein]: Produced by conventional CC translation. {ECO:0000269|PubMed:9813113}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF033808; AAC82560.1; -; Genomic_RNA. DR EMBL; J02342; AAB59932.1; -; Genomic_RNA. DR EMBL; V01197; CAA24512.1; -; Genomic_DNA. DR PIR; A90834; FOFV1R. DR RefSeq; NP_056887.1; NC_001407.1. DR PDB; 1A6S; NMR; -; A=2-87. DR PDB; 1BAI; X-ray; 2.40 A; A/B=578-701. DR PDB; 1EM9; X-ray; 2.05 A; A/B=240-393. DR PDB; 1EOQ; NMR; -; A=394-488. DR PDB; 1P7N; X-ray; 2.60 A; A=215-386. DR PDB; 2IHX; NMR; -; A=503-563. DR PDB; 2RSP; X-ray; 2.00 A; A/B=578-701. DR PDB; 2X8Q; EM; 18.30 A; A=240-465. DR PDB; 3G0V; X-ray; 2.00 A; A=389-465. DR PDB; 3G1G; X-ray; 2.01 A; A/B=390-476. DR PDB; 3G1I; X-ray; 2.10 A; A/B=389-465. DR PDB; 3G21; X-ray; 0.90 A; A=389-465. DR PDB; 3G26; X-ray; 1.55 A; A=389-465. DR PDB; 3G28; X-ray; 1.64 A; A=389-465. DR PDB; 3G29; X-ray; 2.50 A; A/B=389-465. DR PDB; 5A9E; EM; 7.70 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=84-577. DR PDB; 7NO0; EM; 3.10 A; A=240-468. DR PDB; 7NO1; EM; 7.60 A; A/B/C=240-468. DR PDB; 7NO2; EM; 4.30 A; A/B/C=240-468. DR PDB; 7NO3; EM; 5.80 A; A/B/C/D/E=240-468. DR PDB; 7NO4; EM; 7.50 A; A/B/C/D/E/F=240-468. DR PDB; 7NO5; EM; 7.40 A; A/B/C/D/E/F=240-468. DR PDB; 7NO6; EM; 6.00 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NO7; EM; 7.50 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NO8; EM; 7.90 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NO9; EM; 7.60 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOA; EM; 6.40 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOB; EM; 6.70 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOC; EM; 7.80 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOD; EM; 7.80 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOE; EM; 7.50 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOF; EM; 7.60 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOG; EM; 7.80 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOH; EM; 7.10 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOI; EM; 7.20 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOJ; EM; 6.70 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOK; EM; 9.10 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOL; EM; 8.20 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOM; EM; 6.70 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NON; EM; 6.80 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOO; EM; 7.90 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOP; EM; 7.80 A; A/B/C/D/E/F/G/H/I/J=240-468. DR PDB; 7NOQ; EM; 6.50 A; A/B/C/D/E/F/G/H/I/J=240-468. DR BMRB; P03322; -. DR SMR; P03322; -. DR ELM; P03322; -. DR MEROPS; A02.015; -. DR GeneID; 1491923; -. DR KEGG; vg:1491923; -. DR BRENDA; 3.4.23.B10; 5464. DR EvolutionaryTrace; P03322; -. DR CDD; cd05482; HIV_retropepsin_like; 1. DR FunFam; 1.10.375.10:FF:000003; Gag polyprotein; 1. DR Gene3D; 1.10.1200.30; -; 1. DR Gene3D; 2.40.70.10; Acid Proteases; 1. DR Gene3D; 1.10.375.10; Human Immunodeficiency Virus Type 1 Capsid Protein; 1. DR Gene3D; 1.10.150.90; Immunodeficiency lentiviruses, gag gene matrix protein p17; 1. DR Gene3D; 4.10.60.10; Zinc finger, CCHC-type; 1. DR InterPro; IPR001969; Aspartic_peptidase_AS. DR InterPro; IPR004028; Gag_M. DR InterPro; IPR012344; Matrix_HIV/RSV_N. DR InterPro; IPR001995; Peptidase_A2_cat. DR InterPro; IPR021109; Peptidase_aspartic_dom_sf. DR InterPro; IPR050195; Primate_lentivir_Gag_pol-like. DR InterPro; IPR034170; Retropepsin-like_cat_dom. DR InterPro; IPR018061; Retropepsins. DR InterPro; IPR008916; Retrov_capsid_C. DR InterPro; IPR008919; Retrov_capsid_N. DR InterPro; IPR010999; Retrovr_matrix. DR InterPro; IPR001878; Znf_CCHC. DR InterPro; IPR036875; Znf_CCHC_sf. DR PANTHER; PTHR40389; ENDOGENOUS RETROVIRUS GROUP K MEMBER 24 GAG POLYPROTEIN-RELATED; 1. DR PANTHER; PTHR40389:SF3; IGE-BINDING PROTEIN; 1. DR Pfam; PF00607; Gag_p24; 1. DR Pfam; PF02813; Retro_M; 1. DR Pfam; PF00077; RVP; 1. DR Pfam; PF00098; zf-CCHC; 1. DR SMART; SM00343; ZnF_C2HC; 2. DR SUPFAM; SSF50630; Acid proteases; 1. DR SUPFAM; SSF47836; Retroviral matrix proteins; 1. DR SUPFAM; SSF47353; Retrovirus capsid dimerization domain-like; 1. DR SUPFAM; SSF47943; Retrovirus capsid protein, N-terminal core domain; 1. DR SUPFAM; SSF57756; Retrovirus zinc finger-like domains; 1. DR PROSITE; PS50175; ASP_PROT_RETROV; 1. DR PROSITE; PS00141; ASP_PROTEASE; 1. DR PROSITE; PS50158; ZF_CCHC; 1. DR GO; GO:0044196; C:host cell nucleolus; IEA:UniProtKB-SubCell. DR GO; GO:0044095; C:host cell nucleoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0020002; C:host cell plasma membrane; EXP:UniProtKB. DR GO; GO:0019028; C:viral capsid; IEA:UniProtKB-KW. DR GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:UniProtKB-KW. DR GO; GO:0003676; F:nucleic acid binding; IEA:InterPro. DR GO; GO:0039660; F:structural constituent of virion; IEA:UniProtKB-KW. DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0046797; P:viral procapsid maturation; IEA:UniProtKB-KW. DR GO; GO:0075523; P:viral translational frameshifting; IEA:UniProtKB-KW. DR Proteomes; UP000137552; Segment. DR AlphaFoldDB; P03322; -. DR EMDB; EMD-12485; -. DR EMDB; EMD-12486; -. DR EMDB; EMD-12487; -. DR EMDB; EMD-12488; -. DR EMDB; EMD-12489; -. DR EMDB; EMD-12490; -. DR EMDB; EMD-12491; -. DR EMDB; EMD-12492; -. DR EMDB; EMD-12493; -. DR EMDB; EMD-12494; -. DR EMDB; EMD-12495; -. DR EMDB; EMD-12496; -. DR EMDB; EMD-12497; -. DR EMDB; EMD-12498; -. DR EMDB; EMD-12499; -. DR EMDB; EMD-12500; -. DR EMDB; EMD-12501; -. DR EMDB; EMD-12502; -. DR EMDB; EMD-12503; -. DR EMDB; EMD-12504; -. DR EMDB; EMD-12505; -. DR EMDB; EMD-12506; -. DR EMDB; EMD-12507; -. DR EMDB; EMD-12508; -. DR EMDB; EMD-12509; -. DR EMDB; EMD-12510; -. DR EMDB; EMD-12511; -. DR EMDB; EMD-12774; -. DR EMDB; EMD-1710; -. DR EMDB; EMD-3101; -. DR EMDB; EMD-3102; -. DR MDposit; P03322; -. DR MDRepo; P03322; -. PE 1: Evidence at protein level; KW 3D-structure; Aspartyl protease; Capsid protein; Direct protein sequencing; KW Host cell membrane; Host membrane; Host nucleus; Hydrolase; Membrane; KW Metal-binding; Protease; Reference proteome; Repeat; KW Ribosomal frameshifting; Viral capsid assembly; Viral capsid maturation; KW Viral matrix protein; Viral release from host cell; Virion; Zinc; KW Zinc-finger. FT CHAIN 1..701 FT /note="Gag polyprotein" FT /id="PRO_0000442114" FT CHAIN 1..155 FT /note="Matrix protein p19" FT /id="PRO_0000026113" FT CHAIN 156..166 FT /note="p2A" FT /id="PRO_0000026114" FT CHAIN 167..177 FT /note="p2B" FT /id="PRO_0000026115" FT CHAIN 178..239 FT /note="p10" FT /id="PRO_0000026116" FT CHAIN 240..479 FT /note="Capsid protein p27, alternate cleaved 2" FT /id="PRO_0000026117" FT CHAIN 240..476 FT /note="Capsid protein p27, alternate cleaved 1" FT /id="PRO_0000442115" FT PEPTIDE 477..488 FT /note="Spacer peptide" FT /id="PRO_0000026118" FT CHAIN 489..577 FT /note="Nucleocapsid protein p12" FT /id="PRO_0000026119" FT CHAIN 578..701 FT /note="Protease p15" FT /id="PRO_0000026120" FT DOMAIN 609..690 FT /note="Peptidase A2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00275" FT ZN_FING 507..524 FT /note="CCHC-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00047" FT ZN_FING 533..550 FT /note="CCHC-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00047" FT REGION 128..150 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 181..217 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 217..259 FT /note="Involved in capsid protein dimerization" FT /evidence="ECO:0000269|PubMed:14659756" FT REGION 290..298 FT /note="Involved in capsid protein dimerization" FT /evidence="ECO:0000269|PubMed:14659756" FT REGION 351..362 FT /note="Involved in capsid protein dimerization" FT /evidence="ECO:0000269|PubMed:14659756" FT REGION 543..575 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 172..175 FT /note="PPXY motif" FT /evidence="ECO:0000269|PubMed:20392845" FT MOTIF 180..184 FT /note="LYPX(n)L motif" FT /evidence="ECO:0000269|PubMed:20392845" FT MOTIF 219..229 FT /note="Nuclear export signal" FT /evidence="ECO:0000269|PubMed:23036987" FT MOTIF 524..527 FT /note="Nuclear/nucleolar localization signal" FT /evidence="ECO:0000269|PubMed:23036987" FT COMPBIAS 128..141 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 614 FT /note="For protease activity; shared with dimeric partner" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10094" FT SITE 155..156 FT /note="Cleavage; by viral protease p15" FT /evidence="ECO:0000269|PubMed:8627817, FT ECO:0000269|PubMed:8636100" FT SITE 166..167 FT /note="Cleavage; by viral protease p15" FT /evidence="ECO:0000269|PubMed:8627817, FT ECO:0000269|PubMed:8636100" FT SITE 177..178 FT /note="Cleavage; by viral protease p15" FT /evidence="ECO:0000269|PubMed:8627817, FT ECO:0000269|PubMed:8636100" FT SITE 239..240 FT /note="Cleavage; by viral protease p15" FT /evidence="ECO:0000269|PubMed:8627817, FT ECO:0000269|PubMed:8636100" FT SITE 418 FT /note="Involved in capsid protein dimerization upon FT acidification" FT /evidence="ECO:0000269|PubMed:19446529" FT SITE 430 FT /note="Involved in capsid protein dimerization upon FT acidification" FT /evidence="ECO:0000269|PubMed:19446529" FT SITE 476..477 FT /note="Cleavage; by viral protease p15" FT /evidence="ECO:0000269|PubMed:28588198, FT ECO:0000269|PubMed:8627817, ECO:0000269|PubMed:8636100" FT SITE 479..480 FT /note="Cleavage; by viral protease p15" FT /evidence="ECO:0000269|PubMed:28588198, FT ECO:0000269|PubMed:8627817" FT SITE 488..489 FT /note="Cleavage; by viral protease p15" FT /evidence="ECO:0000269|PubMed:8627817, FT ECO:0000269|PubMed:8636100" FT SITE 577..578 FT /note="Cleavage; by viral protease p15" FT /evidence="ECO:0000269|PubMed:8627817, FT ECO:0000269|PubMed:8636100" FT MUTAGEN 172 FT /note="P->A: 75% loss of budding." FT /evidence="ECO:0000269|PubMed:20392845" FT MUTAGEN 180..184 FT /note="LYPSL->AAASA: 40% loss of budding." FT /evidence="ECO:0000269|PubMed:20392845" FT MUTAGEN 219 FT /note="L->A: Reduced nucleolar localization of Gag FT polyprotein." FT /evidence="ECO:0000269|PubMed:23036987" FT MUTAGEN 524..527 FT /note="KKRK->AAAA: Complete loss of nuclear and nucleolar FT localization." FT /evidence="ECO:0000269|PubMed:23036987" FT MUTAGEN 549..551 FT /note="RKR->AAA: Reduced localization in nucleolus; no FT effect on nuclear localization." FT /evidence="ECO:0000269|PubMed:23036987" FT CONFLICT 505 FT /note="A -> S (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 536 FT /note="Q -> E (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" FT HELIX 2..6 FT /evidence="ECO:0007829|PDB:1A6S" FT HELIX 7..15 FT /evidence="ECO:0007829|PDB:1A6S" FT HELIX 28..32 FT /evidence="ECO:0007829|PDB:1A6S" FT HELIX 33..35 FT /evidence="ECO:0007829|PDB:1A6S" FT HELIX 42..46 FT /evidence="ECO:0007829|PDB:1A6S" FT TURN 48..51 FT /evidence="ECO:0007829|PDB:1A6S" FT HELIX 52..60 FT /evidence="ECO:0007829|PDB:1A6S" FT TURN 61..63 FT /evidence="ECO:0007829|PDB:1A6S" FT STRAND 67..71 FT /evidence="ECO:0007829|PDB:1A6S" FT HELIX 72..86 FT /evidence="ECO:0007829|PDB:1A6S" FT HELIX 222..230 FT /evidence="ECO:0007829|PDB:1P7N" FT STRAND 234..236 FT /evidence="ECO:0007829|PDB:1P7N" FT STRAND 241..243 FT /evidence="ECO:0007829|PDB:1EM9" FT STRAND 245..250 FT /evidence="ECO:0007829|PDB:1EM9" FT HELIX 255..268 FT /evidence="ECO:0007829|PDB:1EM9" FT HELIX 273..282 FT /evidence="ECO:0007829|PDB:1EM9" FT HELIX 289..299 FT /evidence="ECO:0007829|PDB:1EM9" FT HELIX 302..325 FT /evidence="ECO:0007829|PDB:1EM9" FT STRAND 334..337 FT /evidence="ECO:0007829|PDB:1P7N" FT HELIX 342..345 FT /evidence="ECO:0007829|PDB:1EM9" FT TURN 350..354 FT /evidence="ECO:0007829|PDB:1EM9" FT HELIX 356..362 FT /evidence="ECO:0007829|PDB:1EM9" FT HELIX 365..385 FT /evidence="ECO:0007829|PDB:1EM9" FT HELIX 392..394 FT /evidence="ECO:0007829|PDB:3G21" FT HELIX 403..415 FT /evidence="ECO:0007829|PDB:3G21" FT STRAND 417..419 FT /evidence="ECO:0007829|PDB:3G21" FT HELIX 421..435 FT /evidence="ECO:0007829|PDB:3G21" FT HELIX 438..444 FT /evidence="ECO:0007829|PDB:3G21" FT HELIX 454..462 FT /evidence="ECO:0007829|PDB:3G21" FT STRAND 510..512 FT /evidence="ECO:0007829|PDB:2IHX" FT HELIX 519..521 FT /evidence="ECO:0007829|PDB:2IHX" FT STRAND 527..529 FT /evidence="ECO:0007829|PDB:2IHX" FT TURN 536..538 FT /evidence="ECO:0007829|PDB:2IHX" FT STRAND 541..543 FT /evidence="ECO:0007829|PDB:2IHX" FT HELIX 545..547 FT /evidence="ECO:0007829|PDB:2IHX" FT STRAND 579..581 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 584..586 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 589..596 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 605..613 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 621..623 FT /evidence="ECO:0007829|PDB:2RSP" FT TURN 624..626 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 633..635 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 650..655 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 657..662 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 672..674 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 677..680 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 682..686 FT /evidence="ECO:0007829|PDB:2RSP" FT HELIX 688..693 FT /evidence="ECO:0007829|PDB:2RSP" FT STRAND 697..699 FT /evidence="ECO:0007829|PDB:2RSP" SQ SEQUENCE 701 AA; 74527 MW; 5FD365D9CFEF37F1 CRC64; MEAVIKVISS ACKTYCGKTS PSKKEIGAML SLLQKEGLLM SPSDLYSPGS WDPITAALSQ RAMILGKSGE LKTWGLVLGA LKAAREEQVT SEQAKFWLGL GGGRVSPPGP ECIEKPATER RIDKGEEVGE TTVQRDAKMA PEETATPKTV GTSCYHCGTA IGCNCATASA PPPPYVGSGL YPSLAGVGEQ QGQGGDTPPG AEQSRAEPGH AGQAPGPALT DWARVREELA STGPPVVAMP VVIKTEGPAW TPLEPKLITR LADTVRTKGL RSPITMAEVE ALMSSPLLPH DVTNLMRVIL GPAPYALWMD AWGVQLQTVI AAATRDPRHP ANGQGRGERT NLNRLKGLAD GMVGNPQGQA ALLRPGELVA ITASALQAFR EVARLAEPAG PWADIMQGPS ESFVDFANRL IKAVEGSDLP PSARAPVIID CFRQKSQPDI QQLIRTAPST LTTPGEIIKY VLDRQKTAPL TDQGIAAAMS SAIQPLIMAV VNRERDGQTG SGGRARGLCY TCGSPGHYQA QCPKKRKSGN SRERCQLCNG MGHNAKQCRK RDGNQGQRPG KGLSSGPWPG PEPPAVSLAM TMEHKDRPLV RVILTNTGSH PVKQRSVYIT ALLDSGADIT IISEEDWPTD WPVMEAANPQ IHGIGGGIPM RKSRDMIELG VINRDGSLER PLLLFPAVAM VRGSILGRDC LQGLGLRLTN L //